"Coronary Restenosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Descriptor ID |
D023903
|
| MeSH Number(s) |
C14.280.647.250.285.200 C14.907.585.250.285.200
|
| Concept/Terms |
Coronary Restenosis- Coronary Restenosis
- Coronary Restenoses
- Restenoses, Coronary
- Restenosis, Coronary
|
Below are MeSH descriptors whose meaning is more general than "Coronary Restenosis".
Below are MeSH descriptors whose meaning is more specific than "Coronary Restenosis".
This graph shows the total number of publications written about "Coronary Restenosis" by people in this website by year, and whether "Coronary Restenosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 2 | 0 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2013 | 1 | 1 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 3 | 0 | 3 |
| 2018 | 1 | 1 | 2 |
| 2019 | 0 | 1 | 1 |
| 2020 | 5 | 1 | 6 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Coronary Restenosis" by people in Profiles.
-
Prognostic impact of in-stent restenosis in normal weight, overweight, and obese patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2024 Feb; 103(2):260-267.
-
Risk Factors for the Development of Carotid Artery In-Stent Restenosis: Multivariable Analysis. Cardiovasc Revasc Med. 2021 03; 24:65-69.
-
Coronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med. 2021 02; 23:28-35.
-
Procedural and 1-year clinical outcomes of orbital atherectomy for treatment of coronary in-stent restenosis: A single-center, retrospective study. Catheter Cardiovasc Interv. 2021 02 15; 97(3):E280-E287.
-
Outcomes With Combined Laser Atherectomy and Intravascular Brachytherapy in Recurrent Drug-Eluting Stent In-Stent Restenosis. Cardiovasc Revasc Med. 2021 01; 22:29-33.
-
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies. Circulation. 2020 03 17; 141(11):891-901.
-
Outcomes of intravascular brachytherapy for recurrent drug-eluting in-stent restenosis. Catheter Cardiovasc Interv. 2021 01 01; 97(1):32-38.
-
Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients. Cardiovasc Revasc Med. 2020 01; 21(1):78-85.
-
Outcomes with drug-coated balloons in small-vessel coronary artery disease. Catheter Cardiovasc Interv. 2019 04 01; 93(5):E277-E286.
-
Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis. Circ Cardiovasc Interv. 2018 10; 11(10):e006832.